Loss of Nfkb1 leads to early onset aging

Aging

Volumn 6, Issue 11, 2014, Pages 931-943

  Bernal, Giovanna M ^a   Wahlstrom, Joshua S ^a   Crawley, Clayton D ^a   Cahill, Kirk E ^a   Pytel, Peter ^a   Liang, Hua ^a   Kang, Shijun ^a   Weichselbaum, Ralph R ^a   Yamini, Bakhtiar ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Aging; CNS gliosis; Nfkb1; Replicative senescence; H2AX

Indexed keywords

DNA; H2AX PROTEIN, MOUSE; HISTONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NFKB1 PROTEIN, MOUSE;

AGE; AGING; ANIMAL; APOPTOSIS; BONE; BRAIN; C57BL MOUSE; CELL AGING; CELL CULTURE; DEFICIENCY; FIBROBLAST; GENETICS; GENOTYPE; GLIOSIS; INFLAMMATION; KNOCKOUT MOUSE; KYPHOSIS; LONGEVITY; METABOLISM; PATHOLOGY; PHENOTYPE; PHOSPHORYLATION; PREMATURE AGING; TIME FACTOR;

AGE FACTORS; AGING; AGING, PREMATURE; ANIMALS; APOPTOSIS; BONE AND BONES; BRAIN; CELL AGING; CELLS, CULTURED; DNA; FIBROBLASTS; GENOTYPE; GLIOSIS; HISTONES; INFLAMMATION; KYPHOSIS; LONGEVITY; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B P50 SUBUNIT; PHENOTYPE; PHOSPHORYLATION; TIME FACTORS;

EID: 84920264332     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100702     Document Type: Article

References (50)

1. Vijg J. Somatic mutations and aging: a re-evaluation. Mutat Res. 2000; 447:117-135.
2. Blagosklonny MV. Aging and immortality: quasi-programmed senescence and its pharmacologic inhibition. Cell Cycle. 2006; 5:2087-2102.
3. Falandry C, Bonnefoy M, Freyer G and Gilson E. Biology of Cancer and Aging: A Complex Association With Cellular Senescence. J Clin Oncol. 2014; Epub ahead of print.
4. Gems D and Partridge L. Genetics of longevity in model organisms: debates and paradigm shifts. Annual review of physiology. 2013; 75:621-644.
5. Campisi J and d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007; 8:729-740.
6. Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL and van Deursen JM. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236.
7. Rana A, Rera M and Walker DW. Parkin overexpression during aging reduces proteotoxicity, alters mitochondrial dynamics, and extends lifespan. Proc Natl Acad Sci U S A. 2013; 110:8638-8643.
8. Adler AS, Sinha S, Kawahara TL, Zhang JY, Segal E and Chang HY. Motif module map reveals enforcement of aging by continual NF-kappaB activity. Genes Dev. 2007; 21:3244-3257.
9. Bernard D, Gosselin K, Monte D, Vercamer C, Bouali F, Pourtier A, Vandenbunder B and Abbadie C. Involvement of Rel/nuclear factor-kappaB transcription factors in keratinocyte senescence. Cancer Res. 2004; 64:472-481.
10. Klein U and Ghosh S. The Two Faces of NF-kappaB Signaling in Cancer Development and Therapy. Cancer Cell. 2011; 20:556-558.
11. Wu ZH and Miyamoto S. Many faces of NF-kappaB signaling induced by genotoxic stress. J Mol Med. 2007; 85:1187-1202.
12. Hayden MS and Ghosh S. NF-kappaB, the first quartercentury: remarkable progress and outstanding questions. Genes Dev. 2012; 26:203-234.
13. Gerondakis S, Grumont R, Gugasyan R, Wong L, Isomura I, Ho W and Banerjee A. Unravelling the complexities of the NFkappaB signalling pathway using mouse knockout and transgenic models. Oncogene. 2006; 25:6781-6799.
14. Sha WC, Liou HC, Tuomanen EI and Baltimore D. Targeted disruption of the p50 subunit of NF-kappa B leads to multifocal defects in immune responses. Cell. 1995; 80:321-330.
15. Schmitt AM, Crawley CD, Kang S, Raleigh DR, Yu X, Wahlstrom JS, Voce DJ, Darga TE, Weichselbaum RR and Yamini B. p50 (NF-kappaB1) is an effector protein in the cytotoxic response to DNA methylation damage. Mol Cell. 2011; 44:785-796.
16. Li H, Vogel H, Holcomb VB, Gu Y and Hasty P. Deletion of Ku70, Ku80, or both causes early aging without substantially increased cancer. Mol Cell Biol. 2007; 27:8205-8214.
17. de Boer J, Andressoo JO, de Wit J, Huijmans J, Beems RB, van Steeg H, Weeda G, van der Horst GT, van Leeuwen W, Themmen AP, Meradji M and Hoeijmakers JH. Premature aging in mice deficient in DNA repair and transcription. Science. 2002; 296:1276-1279.
18. Bousson V, Bergot C, Meunier A, Barbot F, Parlier-Cuau C, Laval-Jeantet AM and Laredo JD. CT of the middiaphyseal femur: cortical bone mineral density and relation to porosity. Radiology. 2000; 217:179-187.
19. Oakley F, Mann J, Nailard S, Smart DE, Mungalsingh N, Constandinou C, Ali S, Wilson SJ, Millward-Sadler H, Iredale JP and Mann DA. Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am J Pathol. 2005; 166:695-708.
20. Bronson RT, Lipman RD and Harrison DE. Age-related gliosis in the white matter of mice. Brain Res. 1993; 609:124-128.
21. Kuilman T, Michaloglou C, Mooi WJ and Peeper DS. The essence of senescence. Genes Dev. 2010; 24(22):2463-2479.
22. Salminen A, Ojala J and Kaarniranta K. Apoptosis and aging: increased resistance to apoptosis enhances the aging process. Cell Mol Life Sci. 2011; 68:1021-1031.
23. Hecht SS. DNA adduct formation from tobacco-specific Nnitrosamines. Mutat Res. 1999; 424:127-142.
24. Xiao W and Samson L. In vivo evidence for endogenous DNA alkylation damage as a source of spontaneous mutation in eukaryotic cells. Proc Natl Acad Sci U S A. 1993; 90:2117-2121.
25. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP and Jackson SP. A DNA damage checkpoint response in telomere-initiated senescence. Nature. 2003; 426:194-198.
26. Pospelova TV, Demidenko ZN, Bukreeva EI, Pospelov VA, Gudkov AV and Blagosklonny MV. Pseudo-DNA damage response in senescent cells. Cell Cycle. 2009; 8:4112-4118.
27. Wang C, Jurk D, Maddick M, Nelson G, Martin-Ruiz C and von Zglinicki T. DNA damage response and cellular senescence in tissues of aging mice. Aging cell. 2009; 8:311-323.
28. Helenius M, Hanninen M, Lehtinen SK and Salminen A. Changes associated with aging and replicative senescence in the regulation of transcription factor nuclear factor-kappa B. Biochem J. 1996; 318:603-608.
29. Tilstra JS, Robinson AR, Wang J, Gregg SQ, Clauson CL, Reay DP, Nasto LA, St Croix CM, Usas A, Vo N, Huard J, Clemens PR, Stolz DB, et al. NF-kappaB inhibition delays DNA damageinduced senescence and aging in mice. J Clin Invest. 2012; 122:2601-2612.
30. Kriete A, Mayo KL, Yalamanchili N, Beggs W, Bender P, Kari C and Rodeck U. Cell autonomous expression of inflammatory genes in biologically aged fibroblasts associated with elevated NF-kappaB activity. Immunity & ageing: I & A. 2008; 5:5.
31. Hoffmann A, Leung TH and Baltimore D. Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. Embo J. 2003; 22:5530-5539.
32. Tilstra JS, Clauson CL, Niedernhofer LJ and Robbins PD. NFkappaB in Aging and Disease. Aging and disease. 2011; 2:449-465.
33. Salminen A, Huuskonen J, Ojala J, Kauppinen A, Kaarniranta K and Suuronen T. Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing research reviews. 2008; 7:83-105.
34. Lu ZY, Yu SP, Wei JF and Wei L. Age-related neural degeneration in nuclear-factor kappaB p50 knockout mice. Neuroscience. 2006; 139:965-978.
35. Lang H, Schulte BA, Zhou D, Smythe N, Spicer SS and Schmiedt RA. Nuclear factor kappaB deficiency is associated with auditory nerve degeneration and increased noise-induced hearing loss. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2006; 26:3541-3550.
36. Takahashi Y, Katai N, Murata T, Taniguchi SI and Hayashi T. Development of spontaneous optic neuropathy in NFkappaBetap50-deficient mice: requirement for NFkappaBetap50 in ganglion cell survival. Neuropathology and applied neurobiology. 2007; 33:692-705.
37. Denis-Donini S, Dellarole A, Crociara P, Francese MT, Bortolotto V, Quadrato G, Canonico PL, Orsetti M, Ghi P, Memo M, Bonini SA, Ferrari-Toninelli G and Grilli M. Impaired adult neurogenesis associated with short-term memory defects in NFkappaB p50-deficient mice. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2008; 28:3911-3919.
38. Nichols NR, Day JR, Laping NJ, Johnson SA and Finch CE. GFAP mRNA increases with age in rat and human brain. Neurobiol Aging. 1993; 14:421-429.
39. Finch CE. Neurons, glia, and plasticity in normal brain aging. Neurobiol Aging. 2003; 24 Suppl 1:S123-127; discussion S131.
40. Hequembourg S and Liberman MC. Spiral ligament pathology: a major aspect of age-related cochlear degeneration in C57BL/6 mice. Journal of the Association for Research in Otolaryngology: JARO. 2001; 2:118-129.
41. Rajendrasozhan S, Chung S, Sundar IK, Yao H and Rahman I. Targeted disruption of NF-{kappa}B1 (p50) augments cigarette smoke-induced lung inflammation and emphysema in mice: a critical role of p50 in chromatin remodeling. Am J Physiol Lung Cell Mol Physiol. 2010; 298:L197-209.
42. Fullard N, Moles A, O'Reilly S, van Laar JM, Faini D, Diboll J, Reynolds NJ, Mann DA, Reichelt J and Oakley F. The c-Rel subunit of NF-kappaB regulates epidermal homeostasis and promotes skin fibrosis in mice. Am J Pathol. 2013; 182:2109-2120.
43. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell. 2005; 120:513-522.
44. Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Res. 1995; 55:2284-2292.
45. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC and Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007; 128:92-105.
46. Korhonen P, Helenius M and Salminen A. Age-related changes in the regulation of transcription factor NF-kappa B in rat brain. Neurosci Lett. 1997; 225:61-64.
47. Xiao ZQ and Majumdar AP. Induction of transcriptional activity of AP-1 and NF-kappaB in the gastric mucosa during aging. Am J Physiol Gastrointest Liver Physiol. 2000; 278:G855-865.
48. Radak Z, Chung HY, Naito H, Takahashi R, Jung KJ, Kim HJ and Goto S. Age-associated increase in oxidative stress and nuclear factor kappaB activation are attenuated in rat liver by regular exercise. Faseb J. 2004; 18:749-750.
49. Kim HJ, Kim KW, Yu BP and Chung HY. The effect of age on cyclooxygenase-2 gene expression: NF-kappaB activation and IkappaBalpha degradation. Free Radic Biol Med. 2000; 28:683-692.
50. Helenius M, Kyrylenko S, Vehvilainen P and Salminen A. Characterization of aging-associated up-regulation of constitutive nuclear factor-kappa B binding activity. Antioxid Redox Signal. 2001; 3:147-156.